World's Best Scientists 2026 revealed!
Bernard M. J. Uitdehaag

Bernard M. J. Uitdehaag

D-Index & Metrics

Medicine

D-Index
90
Citations
39255
World Ranking
12035
National Ranking
465

Overview

Bernard M. J. Uitdehaag is affiliated with Amsterdam UMC in the Netherlands and has focused their research career primarily on medicine, with a notable emphasis on multiple sclerosis and related neurological conditions. Their extensive publication record reflects deep engagement with both clinical and epidemiological aspects of neurological diseases and autoimmune disorders.

Their main fields of study include:

  • Medicine

Their work spans several specialized subfields, such as:

  • Pathology and Forensic Medicine
  • Neurology
  • Rheumatology
  • Oncology
  • Epidemiology

Bernard M. J. Uitdehaag's research contributions cover multiple topics, particularly focusing on:

  • Multiple Sclerosis Research Studies
  • Polyomavirus and related diseases
  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Peripheral Neuropathies and Disorders
  • Functional Brain Connectivity Studies
  • Neurogenesis and neuroplasticity mechanisms

The scientist has authored or co-authored papers published in various journals. Frequent publication venues include:

  • Multiple Sclerosis Journal
  • Multiple Sclerosis and Related Disorders
  • Journal of Neurology
  • Neurology
  • NeuroImage Clinical

Several notable recent papers authored or co-authored by Bernard M. J. Uitdehaag include:

  • "Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition" (2020), published in Multiple Sclerosis Journal
  • "Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial" (2021), published in The Lancet Neurology
  • "Longitudinal Assessment of Multiple Sclerosis with the Brain-Age Paradigm" (2020), published in Annals of Neurology
  • "Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic" (2021), published in Multiple Sclerosis Journal
  • "Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study" (2020), published in CNS Drugs

Frequent collaborators include:

  • Eva Strijbis
  • Frederik Barkhof
  • Joep Killestein
  • Menno M. Schoonheim
  • Brigit A. de Jong

Best Publications

  • Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

    Alan J. Thompson;Brenda L. Banwell;Frederik Barkhof;Frederik Barkhof;William M. Carroll

  • Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition.

    Clare Walton;Rachel King;Lindsay Rechtman;Wendy Kaye

  • Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

    Philip L De Jager;Philip L De Jager;Xiaoming Jia;Joanne Wang;Paul I W de Bakker

  • Exercise therapy for multiple sclerosis

    Marc B. Rietberg;Dina Brooks;Bernard M.J. Uitdehaag;Gert Kwakkel

  • PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS

    G Francis;R Hughes;J King;P Mitchell

  • Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis.

    Rosa E. Boeschoten;Rosa E. Boeschoten;Annemarie M.J. Braamse;Annemarie M.J. Braamse;Aartjan T.F. Beekman;Aartjan T.F. Beekman;Pim Cuijpers

  • Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

    Daniel D Mikol;Frederik Barkhof;Peter Chang;Patricia K Coyle

  • Intracortical Lesions in Multiple Sclerosis: Improved Detection with 3D Double Inversion-Recovery MR Imaging

    Jeroen J. G. Geurts;Petra J. W. Pouwels;Bernard M. J. Uitdehaag;Chris H. Polman

  • Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages.

    I. Huitinga;N. Van Rooijen;C. J. A. De Groot;B. M. J. Uitdehaag

  • Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

    Sergio E. Baranzini;Joanne Wang;Rachel A. Gibson;Nicholas Galwey

  • Multiple Sclerosis: Current Knowledge and Future Outlook

    Christian Philipp Kamm;Bernard M. Uitdehaag;Chris H. Polman

  • Pathway and network-based analysis of genome-wide association studies in multiple sclerosis

    Sergio E. Baranzini;Nicholas W. Galwey;Joanne Wang;Pouya Khankhanian

  • Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

    Fred Lublin;David H Miller;Mark S Freedman;Bruce A C Cree

  • Brain atrophy and lesion load predict long term disability in multiple sclerosis

    Veronica Popescu;Federica Agosta;Hanneke E Hulst;Ingrid C Sluimer

  • Progression of regional grey matter atrophy in multiple sclerosis.

    Arman Eshaghi;Arman Eshaghi;Razvan V Marinescu;Alexandra L Young;Nicholas C Firth

  • Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS

    L. Kappos;A. Traboulsee;C.S. Constantinescu;J.P. Eralinna

  • Surgical treatment options for carpal tunnel syndrome

    Rob J.P.M. Scholten;A. Mink Van Der Molen;B. M.J. Uitdehaag;L. M. Bouter

  • Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI

    J.J.G. Geurts;S.D. Roosendaal;M. Calabrese;O. Ciccarelli

  • Bright light treatment in elderly patients with nonseasonal major depressive disorder: A randomized placebo-controlled trial.

    Ritsaert Lieverse;Eus J. W. Van Someren;Marjan M. A. Nielen;Bernard M. J. Uitdehaag

  • Safety, tolerability, and efficacy of orally administered cannabinoids in MS

    J. Killestein;E. L.J. Hoogervorst;M. Reif;N. F. Kalkers

Frequent Co-Authors

Chris H. Polman
Chris H. Polman VU University Medical Center
Frederik Barkhof
Frederik Barkhof University College London
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Jeroen J. G. Geurts
Jeroen J. G. Geurts Vrije Universiteit Amsterdam
Axel Petzold
Axel Petzold University College London
Dirk L. Knol
Dirk L. Knol VU University Medical Center
Mike P. Wattjes
Mike P. Wattjes Hannover Medical School
Mark S. Freedman
Mark S. Freedman Ottawa Hospital
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona
Prejaas Tewarie
Prejaas Tewarie University of Twente

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to many healthcare careers beyond the traditional MD path. Many students look for easy nursing programs to get into as a direct route into patient care. These programs may offer more accessible admissions compared to medical schools.

For those interested in the administrative side, medical billing and coding schools online provide training for essential roles in healthcare management. These online options are flexible and often available with financial aid to support your studies.

If entrance exams are a concern, some choose a nursing school without teas test requirements, making the application process simpler for aspiring nurses.

Another great option is an online healthcare administration degree. These accelerated programs help students quickly transition into leadership or management roles in hospitals, clinics, and other medical settings.

Best Scientists Citing Bernard M. J. Uitdehaag

Trending Scientists

Recently Published Articles